You are here

  • Home
  • Archive
  • Volume 57, Issue Suppl
  • Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.

Article info

Article menu
Download PDFPDF
Research Article
Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.

Authors

    Citation

    Noseworthy JH, O'Brien PC, van Engelen BG, et al
    Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.
    Journal of Neurology, Neurosurgery & Psychiatry 1994;57:11-14.

    Publication history

    • First published November 1, 1994.
    Online issue publication 
    April 13, 2016

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.